New incident report
Incident Report Number: 2009-4282
Registrant Reference Number: Prosar 1-19644779
Registrant Name (Full Legal Name no abbreviations): Syngenta Crop Protection Canada, Inc.
Address: 140 Research Lane, Research Park
City: Guelph
Prov / State: Ontario
Country: Canada
Postal Code: N1G4Z3
Human
Country: UNITED STATES
Prov / State: LOUISIANA
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No.
Product Name: non-specific Demon (Cypermethrin-based insecticide)
Liquid
Yes
Unknown
Site: Res. - In Home / Rés. - à l'int. maison
Unknown
Medical Professional
Sex: Female
Age: >19 <=64 yrs / >19 <=64 ans
System
Unknown / Inconnu
Yes
Yes
Unknown
Non-occupational
Contact with treated area
Amount of time between application and contact 8
Hour(s) / Heure(s)
Unknown
Unknown
Unknown / Inconnu
Unknown / Inconnu
1-19644779: A reporter (physician) called on 08/26/2009 to report the exposure of a patient to an insecticide containing the active ingredient Cypermethrin. According to the reporter, the product was applied to the patient's home 10 days prior to the report (08/16/2009). The patient left the home at the time of product application and did not return home for 8 hours. At an unknown time following product application, the patient developed several episodes of facial swelling which required treatment at an emergency room. At the time of the report, the patient had angioedema and pneumonia and was being admitted to the hospital. The reporter was advised that the active ingredient is a pyrethroid which are typically diluted when applied. The product can be an irritant to the upper respiratory tract if inhaled and an irritant to the skin if dermal contact with wet product occurs. Once the product has dried, adverse signs are not expected. If the patient did contact wet product, hypersensitivity is possible but is a rare occurrence. Angioedema and pneumonia are not reported events with routine use of the product. The reporter was provided a Material Safety Data Sheet. On follow up on 08/28/2009, a nurse stated that the patient's pneumonia was persistent and that she was coughing up a thick green material. Her lung sounds were diminished but she did not require supplemental oxygen. The patient was receiving respiratory treatments every 6 hours and was afebrile. No further information was obtained.
Major
The signs described are not consistent with exposure to dried product residue. Exposure in this case is unknown. Re-entry interval is until dry. Patient did not return for 8 hours, therefore re-entry interval was exceeded and exposure unlikely.